Funder
Agentschap voor Innovatie door Wetenschap en Technologie
Belgian Animal Cancer Foundation
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Denekamp, J. The tumour microcirculation as a target in cancer therapy: a clearer perspective. European Journal of Clinical Investigation 29, 733–736 (1999).
2. Chen, B., Roskams, T. & De Witte, P. A. M. Antivascular tumor eradication by hypericin-mediated photodynamic therapy. Photochemistry and Photobiology 76, 509–513 (2002).
3. Dark, G. G. et al. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Cancer Research 57, 1829–1834 (1997).
4. Chaplin, D. J., Pettit, G. R. & Hill, S. A. Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate. Anticancer Research 19, 189–196 (1999).
5. Grosios, K., Holwell, S. E., McGown, A. T., Pettit, G. R. & Bibby, M. C. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate pro-drug. British Journal of Cancer 81, 1318–1327 (1999).
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献